We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+2.32%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$513M
AUM Growth
-$74.9M
Cap. Flow
-$71.4M
Cap. Flow %
-13.92%
Top 10 Hldgs %
16.18%
Holding
249
New
34
Increased
44
Reduced
101
Closed
55

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$6.87M
2
MGY icon
Magnolia Oil & Gas
MGY
+$6.85M
3
TDW icon
Tidewater
TDW
+$6.69M
4
CADE
Cadence Bank
CADE
+$6.45M
5
COCO icon
Vita Coco
COCO
+$5.32M

Top Sells

Rank Stock Value
1
SN icon
SharkNinja
SN
+$9.45M
2
CNS icon
Cohen & Steers
CNS
+$9.41M
3
BWXT icon
BWX Technologies
BWXT
+$8.27M
4
STAG icon
STAG Industrial
STAG
+$6.59M
5
PR
Permian Resources
PR
+$6.56M

Sector Composition

Rank Sector Weight
1 Healthcare 17.37%
2 Industrials 16.17%
3 Financials 14.84%
4 Consumer Discretionary 13.64%
5 Technology 13.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CTRA
101
DELISTED
Coterra Energy
CTRA
$1.77M 0.35%
66,529
– –
BBY icon
102
Best Buy
BBY
$17.3B
$1.74M 0.34%
20,661
– –
CRC icon
103
California Resources
CRC
$4.62B
$1.69M 0.33%
+31,700
New +$1.62M
VTRS icon
104
Viatris
VTRS
$19.1B
$1.67M 0.33%
157,316
– –
TOL icon
105
Toll Brothers
TOL
$14.5B
$1.62M 0.32%
14,059
-4,779
-25% -$578K
ACLX
106
DELISTED
Arcellx
ACLX
$1.51M 0.29%
27,337
+6,777
+33% +$368K
ALKS icon
107
Alkermes
ALKS
$8.25B
$1.5M 0.29%
62,066
-4,142
-6% -$102K
MDGL icon
108
Madrigal Pharmaceuticals
MDGL
$11.8B
$1.35M 0.26%
4,814
-310
-6% -$73.8K
MSFT icon
109
Microsoft
MSFT
$3.71T
$1.33M 0.26%
2,986
-231
-7% -$97.6K
CF icon
110
CF Industries
CF
$17.3B
$1.32M 0.26%
17,819
-6,169
-26% -$479K
VKTX icon
111
Viking Therapeutics
VKTX
$4B
$1.3M 0.25%
24,465
-31,270
-56% -$2.05M
ARWR icon
112
Arrowhead Research
ARWR
$12.4B
$1.3M 0.25%
49,879
-3,160
-6% -$77.7K
GPCR icon
113
Structure Therapeutics
GPCR
$3.78B
$1.09M 0.21%
+27,684
New +$1.14M
NVDA icon
114
NVIDIA
NVDA
$5.42T
$1.08M 0.21%
8,745
-4,315
-33% -$436K
PRAX icon
115
Praxis Precision Medicines
PRAX
$10.1B
$1.01M 0.2%
+24,381
New +$1.15M
WVE icon
116
Wave Life Sciences
WVE
$1.2B
$895K 0.17%
+179,359
New +$1.02M
AMZN icon
117
Amazon
AMZN
$2.96T
$815K 0.16%
4,219
+6
+0.1% +$1.1K
LLY icon
118
Eli Lilly
LLY
$1.06T
$672K 0.13%
742
-579
-44% -$463K
BWXT icon
119
BWX Technologies
BWXT
$15.6B
$650K 0.13%
6,841
-89,188
-93% -$8.27M
CLH icon
120
Clean Harbors
CLH
$16.3B
$631K 0.12%
2,791
-19,423
-87% -$4.07M
SN icon
121
SharkNinja
SN
$26.1B
$596K 0.12%
7,927
-134,229
-94% -$9.45M
EWBC icon
122
East-West Bancorp
EWBC
$18B
$586K 0.11%
8,007
-4
-0% -$297
DECK icon
123
Deckers Outdoor
DECK
$13.3B
$575K 0.11%
3,564
-6
-0.2% -$923
JPM icon
124
JPMorgan Chase
JPM
$950B
$560K 0.11%
2,769
+6
+0.2% +$1.17K
FINV
125
FinVolution Group
FINV
$1.15B
$547K 0.11%
+114,663
New +$561K
3 4
5
6 7

Similar funds

CAM
Cander Asset Management New York $557M AUM
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return
CFP
Curran Financial Partners Daniel Island, South Carolina $559M AUM 13.69% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return
DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $553M AUM 1.32% 1-Year Est. Return

Moody Aldrich Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Moody Aldrich Partners held 249 positions worth $513M, down 13% from $588M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Moody Aldrich Partners withdrew a net $71.4M in Q2 2024, closing 55 positions and reducing 101 holdings. Its most notable exit was Cohen & Steers, an estimated $9.41M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

Against the trend, Moody Aldrich Partners opened a new position in Intra-Cellular Therapies Inc. worth $6.78M.

  • Moody Aldrich Partners's largest Q2 2024 buy was Intra-Cellular Therapies Inc.: 99,012 shares worth $6.78M.
  • Moody Aldrich Partners added most to Crinetics Pharmaceuticals in Q2 2024, an estimated $4.33M increase.
  • Moody Aldrich Partners's biggest Q2 2024 reduction was SharkNinja, cutting an estimated $9.45M.
  • Moody Aldrich Partners fully exited Cohen & Steers in Q2 2024, selling an estimated $9.41M.
  • Moody Aldrich Partners's ten largest holdings make up 16% of its $513M portfolio in Q2 2024.
  • Moody Aldrich Partners opened 34 new positions and closed 55 in Q2 2024.
  • Moody Aldrich Partners's portfolio value fell 13% quarter-over-quarter to $513M.

Based on Moody Aldrich Partners's 13F filing for Q2 2024, filed 24 Jul 2024.